Research & Peer Review Studies

Clinical Study of The Superior Edition (LEXIRIN) ®
(October 1, 2005 - September 1, 2012).
Test article: Kenrico Sap Sheet Superior Edition (LEXIRIN ®)


OBJECTIVE
Apoptosis is a normal physiologic process that leads to individual cell death. This process of programmed cell death is involved in a variety of normal and pathogenic biological events and can be induced by a number of unrelated stimuli. Changes in the biological regulation of apoptosis also occur during aging and are responsible for many of the conditions and diseases related to aging. Apoptotic cell death appears to play a significant role in the tissue damage that occurs in association with various abnormal conditions, for example, ischemia and various gastrointestinal disorders.


Ischemia is the result of deceased blood flow to a particular area or organ of the body. Ischemia is responsible for several important types of physiologic damage such as brain damage, spinal cord trauma and myocardial ischemia.


RESULTS
Human clinical trials with 300 number of participants confirmed the positive effects of Superior Edition (LEXIRIN) in treating gastrointestinal disorders and other wide range of diseases including Alzheimer's disease.


The human clinical trials has passed Phase I Trial by USFDA. In 20 patients receiving radiotherapy (out of 300 participants), clinical study showed significant positive results with the early post-operative return to nitrogen balance, early return of bowel sounds, no severe or bloody diarrhea and decreased hospitalization.


The Superior Edition (LEXIRIN) is manufactured using advanced water extraction and protected with patent US6,413,556 and US6,793,945



The Superior Edition (LEXIRIN) provides the anti-apoptotic compositions produced by extracting nattokinase out of organic soybean with the addition of SOD (Superoxide Dismutase), referred to as Lexirin. LEXIRIN pads can be used to treat or prevent an adverse condition associated with apoptosis (cell death, cell damage or organs' damage), including gastrointestinal disorders, deleterious dermatological conditions, immunosuppression or immunodeficiency, reperfusion damage resulting from ischemia, cardiovascular disorders, wound healing, transplantation, tissue rejection and Alzheimer's disease.


The effectiveness of the Superior Edition (LEXIRIN) in shielding gastrointestinal tracts against damages and preventing diarrhea:



The effectiveness of the Superior Edition (LEXIRIN) in preventing organs damage from aging or radicals. The composition of LEXIRIN can be used as an elixir of life for prolonging the lifespan of normal healthy human or human with severe illness (such as HIV):



  • REVEALING THE SECRET OF TRMX-3 30th ANNIVERSARY
    July 4 2014 - February 14 2015
  • FAT AND CELLULITE RESEARCH OF DIAMOND HYBRID EDITION (DHE)
    June 2 2013 - July 11 2013
  • NATURAL ENERGY RESEARCH OF DIAMOND HYBRID EDITION (DHE)
    October 27 2013
  • DEFENSOR II STUDY OF TRMX-3
    May, 2011 - February 28, 2013
  • LEXIRIN PADS AS ELIXIR OF LIFE
    October 1 2005 - September 1 2012
  • TRMX-3 BOOSTS MENTAL AND PHYSICAL HEALTH
    February 1 2011 - March 1 2011
  • ZEO REMOVES HEAVY METALS
    December 5 2008 - March 6 2009
  • MICROSCOPIC RESEARCH
    June 11 2008
  • LIFESTYLE AND BLOOD ANALYSIS
    October 25 2006 - April 25 2007
  • LDL CHOLESTEROL AND TRIGLYCERIDES REDUCED
    May 30 2006
  • HEAVY METALS RESEARCH (ADDITIONAL REPORT)
    October 7 2005
  • HEAVY METALS RESEARCH
    January 18 2005
  • NEGATIVE IONS RESEARCH
    June 14 2004
  • FAR INFRARED RESEARCH
    June 3 2004
  • BRAIN WAVE RESEARCH
    June 6 2003
  • QUALITY & SAFETY TESTING